A Six-Gene Assay as a New Biomarker in the Blood of Patients With Colorectal Cancer: Establishment and Clinical Validation

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)

Journal of Pharmacogenomics & Pharmacoproteomics
2017English

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

Identification and Clinical Validation of a Novel 4 Gene-Signature With Prognostic Utility in Colorectal Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

BRAF Mutation as a Biomarker in Colorectal Cancer

Advances in Genomics and Genetics
2015English

Biomarker Assay Validation

Bioanalysis
PharmacologyAnalytical ChemistryMedical Laboratory TechnologyClinical BiochemistryMedicineToxicologyPharmaceutics
2018English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Identification of a New Protein Biomarker for Colorectal Cancer Diagnosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

Human Epididymis Protein-4 Gene Expression as a Biomarker in Patients With Ovarian Cancer in Iran

Open Journal of Clinical Diagnostics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy